This laboratory was recently asked to provide an opinion regarding the validity of a hospital laboratory alcohol level in a criminal case. The test was an alcohol dehydrogenase (ADH)-based serum ethanol determination. A question was raised regarding the validity of the ethanol value due to the possibility of the assay reflecting a "false positive" result as a consequence of lactate dehydrogenase (LDH)-catalyzed oxidation of lactate present in the sample. In this case, neither lactate nor LDH levels were measured in the patient sample, which forced an evaluation and response based on other clinically measured parameters and information regarding the specific assay utilized for the ethanol analysis. This approach may be a useful model for other practitioners to consider in similar cases.
Introduction
This laboratory was recently asked to provide an opinion regarding the validity of a hospital laboratory alcohol level in a criminal case. The test was an alcohol dehydrogenase (ADH)-based serum ethanol determination. A question was raised regarding the validity of the ethanol value due to the possibility of the assay reflecting a "false positive" result as a consequence of lactate dehydrogenase (LDH)-catalyzed oxidation of lactate present in the sample. In this case, neither lactate nor LDH levels were measured in the patient sample, which forced an evaluation and response based on other clinically measured parameters and information regarding the specific assay utilized for the ethanol analysis. This approach may be a useful model for other practitioners to consider in similar cases.
The enzymatic ethanol method used by the hospital (Roche Ethanol Gen.2), and typical of such assays, is an initial rate method based on the rate of appearance of reduced nicotinamide adenine dinucleotide (NADH; λ max ← 340 nm) as a function of ethanol oxidation catalyzed by ADH (1) . Similarly, oxidation of lactate to pyruvate by LDH also produces NADH (2) and, if generated in the ADH-assay mix, would be interpreted as ethanol oxidation and hence, as a false "ethanol" result. Although recognized as a potential confounder of the assay, neither lactate nor LDH is regularly present in the serum at levels that could affect the validity of the ADH assay.
LDH is primarily a hepatocellular, cytosolic enzyme not usually significantly present in the blood. LDH and other cytosolic enzymes may be released from the liver as a consequence of abdominal trauma and damage to hepatocytes or chronic liver injury or dysfunction [e.g., cirrhosis, hepatocellular necrosis, or inflammation (3)]. Hepatocellular damage may be assessed by evaluation of levels of such hepatic enzymes in serum. Typically, aspartate aminotransferase (ASAT) and alanine aminotransferase (ALAT) are used clinically to assess hepatic trauma (4) . Therefore, the appearance of LDH, ASAT, and ALAT in serum levels in a trauma case are indicative of such injury (3, 4) .
Lactate (the anionic form of β-hydroxypropanoic acid) is a metabolic intermediate with blood reference levels being 0.9-1.7 mmol/L (5). Lactate is the end product of anaerobic glycolysis and also the glycolytic end product in red blood cells. Lactate is readily taken up from the blood by the liver and utilized in gluconeogenesis (6) . Lactate blood levels may be elevated when local tissues are hypoxic (e.g., hypovolemic shock, myocardial infarction, pulmonary edema, or musculoskeletal trauma). Blood lactate may also be temporarily elevated because the patient received treatment in the form of Lactated Ringer's solution (which contains 28 mmol/L lactate). In this case, there was no indication in the medical record that the patient received Lactated Ringer's solution.
LDH normally functions as a reductase, producing lactate from the β-keto analogue pyruvate (as a gluconeogenic pre-cursor) and oxidized NAD + . In the circumstance of elevated lactate and in the presence of excess NAD + (as would be found in an ADH-based EtOH assay), the reversible reaction oxidizes lactate to pyruvate with the concomitant reduction of NAD + to NADH+H + ( Figure 1 ). Therefore, it is reasonable to suggest that a serum sample containing both LDH and lactate could produce a false-positive result in an ADH-based EtOH assay as the excess NAD drives the reaction towards pyruvate. The essential condition for a false positive contribution is that there be enough LDH and lactate to actually compete with the ADHethanol system. Thompson et al. (7) have shown that lactatebased interference with the assay disappears in ultrafiltered (hence LDH-free) serum samples, emphasizing the need for both enzyme (LDH) and substrate (lactate) to be present for the interfering reaction to proceed. Some assays determine the initial rate of NADH production prior to the addition of ADH as a baseline value. Then following the addition of ADH to the reaction mix, the new initial rate (minus the "baseline" rate) is reflective of ADH-catalyzed oxidation and, hence, ethanol concentration. In this manner, the assay can be "controlled" for the presence of lactate and LDH.
In our experience, the suggestion of lactate/LDH interference has been argued in court on a strictly theoretical basis or based only on the possibility of lactate being present. Lactate, a β-hydroxy carboxylic acid, is not a substrate for ADH, which catalyzes the oxidation of short-chain aliphatic alcohols (8) . In the absence of LDH, the presence of lactate alone is not, therefore, an adequate basis for the suggestion of interference with ADH-based ethanol assays.
We had the opportunity with this case to present a numerically-based evaluation of the potential for LDH-based interference. Because the potentially competing reaction is dependent upon the amount of lactate and LDH in the assay, we evaluated clinical parameters to estimate reasonable maximal levels for both lactate and LDH. We then calculated the amount of each that would be present in the assay vessel based on the sampling aliquot.
Case History
The driver in this case (a 33-year-old male) was involved in a single motor vehicle collision by impacting a tree. He was transported to a local hospital emergency department, and blood was drawn shortly thereafter. There was neither radiological nor surgical evidence for intraabdominal organ injury; however, some of his measured serum hepatic and pancreatic enzyme levels were elevated, which was suggestive of some degree of trauma. The authors made the conservative assumption of minor liver injury based upon the approximate fivefold increase of ALAT and eightfold increase of ASAT as compared to the midpoints of the hospital reference ranges (Table I) . Because of the rapidity with which hospital testing was performed, aging of samples was not considered to be a significant factor in this case. The treating hospital performed a standard panel of laboratory tests, including a serum alcohol determination using a method based on the rate of NAD reduction by ADH. Serum ethanol was reported as 200 mg/dL, yielding an approximate whole blood % ethanol of 0.17 g/dL. Hospital laboratory results were obtained by warrant, and results of the alcohol test were admitted into evidence during criminal proceedings. Pertinent clinical laboratory findings were as noted in Table I 2 ]). The reference range for anion gap is 8-15 (9); therefore, in this case, the anion gap was not elevated. The assay utilized by the hospital laboratory (Roche Ethanol Gen.2) mixes 50 µL of a 37 mU/µL ADH solution with 4-µL sample (1). The assay is an "initial rate" method using ∆A 340 as the monitored variable.
Results and Discussion
This case was focused on the validity of the alcohol determination performed by the hospital laboratory. Although it had been suggested that lactate alone can interfere with the ADH-based assay by "cross-reaction," lactate, as noted previously (8), is not an effective substrate for ADH. It is, however, reasonable to suggest that the combination of high levels of both lactate and LDH can, in the presence of the excess NAD + in the assay, produce NADH and thereby cause a falsely elevated ethanol reading as reported by Nine et al. (10), who also demonstrated the differential susceptibility of specific assays to this interference. Serum lactate increases rapidly after death, even in the early postmortem period (11) . In postmortem samples, it can be reasonably assumed that intracellular material, including lactate and LDH, have been released into the blood as cellular membrane integrity degrades. For this reason, enzymaticbased alcohol analyses are generally recognized as unreliable when used on postmortem samples. (Such determinations are normally performed using the more specific headspace gas chromatography methodology.)
We considered the (albeit indirect) evidence addressing the likelihood of both LDH and lactate being present in the assay mix from this specific case. First, anion gap is well-recognized as an indicator of lactic acidosis, or elevated lactate generated by metabolic processes. In the case noted previously, the anion gap was not elevated at 8 mmol/L, reference range 8-15 mmol/L (9), a result that is inconsistent with significantly elevated serum lactate. However, we did note that the chloride level was slightly elevated, and carbon dioxide was slightly low. We could not preclude the possibility of a correspondingly slightly elevated serum lactate level of~2-8 meq/L based on the anion gap result. As noted previously, normal lactate levels are~1 meq/L. In comparison, a 0.2 g/dL level of ethanol corresponds to~40 meq/L ethanol, so in this case the ratio of ethanol to lactate was probably at least 5:1. So, in the hypothetical case of a 5:1 ethanol/lactate ratio and equivalent amounts of corresponding enzymes (ADH and LDH), we would expect that the rate of the ethanol/ADH reaction would be at least five times the rate of the lactate/LDH reaction.
The second essential element of consideration is the level of LDH. This enzyme may be released as a function of trauma. When the liver is injured, hepatocytes rupture, and their cytosolic contents (enzymes, etc.) spill into the local blood stream and then the general circulation. Trauma-induced enzyme leakage is non-selective; all the elements that had been contained in the once-intact hepatocytes are released into the blood. Because the mechanism of release is non-specific, one can use the levels of other hepatic enzymes as a general indicator of the extent to which hepatic LDH could reasonably have leaked into the blood. We reasoned that the hepatic enzymes ASAT and ALAT would provide a reasonable indication of the extent of LDH release. The usual LDH blood level is~200 U/L (3). In this case, ASAT and ALAT were elevated~eight-andf ivefold, respectively. Therefore, we conservatively estimated that LDH was maximally elevated approximately 10-fold. This would yield a serum concentration of~2000 U/L, or 2 mU/µL. The 4-µL sample volume used in the enzyme assay would therefore maximally include 8 mU of LDH in the mix. In contrast, the assay mix receives 1850 mU of ADH (this is an assayspecific parameter and would be expected to vary between manufacturers). This > 200-fold excess of ADH to LDH suggests that even with equivalent concentrations of ethanol and lactate (~40 meq/L, which we did not have in this case), the contribution of lactate to the final result would be 1 part in 200. In a serum alcohol result of 200 mg/dL correcting for lactate contribution would yield a 199 mg/dL. Combination of the two factors leads to our expectation that the ethanol level in the assay was at least five times the lactate level, and the ADH level was at least two hundred times the LDH level. Therefore, we concluded that there would be no significant contribution to the ethanol reading in the assay due to the oxidation of lactate.
Conclusions
A potentially legitimate challenge to the validity of an enzymatically based ethanol assay may be raised based on the presence of both lactate and LDH. Although that contention can be argued on a theoretical basis, evaluation of clinical values provides useful information regarding reasonable concentrations of both lactate and LDH that may be present in a specific case. Neither the presence of lactate nor LDH alone provides an adequate basis to suggest interference with typical ADH-based assays. Hence, clinical data indicating levels of lactate and LDH within reference ranges may be adequate to disprove the interference challenge. Actual calculation of the amount of ADH present in the reaction vessel in comparison to maximal estimates of the amount of LDH available (again based on clinical laboratory values) may provide an even stronger basis for the evaluation of interference potential from lactate and LDH.
